Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 79, 2019 - Issue 7
Submit an article Journal homepage
151
Views
1
CrossRef citations to date
0
Altmetric
Letter to the Editor

Low serum calprotectin levels correlate with the presence of biological drugs after the first year of treatment in patients with rheumatoid arthritis

Ana Martínez-FeitoImmuno-Rheumatology Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain;Immunology Unit, La Paz University Hospital, Madrid, SpainCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-5580-8387View further author information
ORCID Icon,
Chamaida Plasencia-RodríguezImmuno-Rheumatology Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain;Rheumatology Department, La Paz University Hospital, Madrid, SpainView further author information
,
Victoria Navarro-CompánImmuno-Rheumatology Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain;Rheumatology Department, La Paz University Hospital, Madrid, SpainView further author information
,
Andrea JochemsImmuno-Rheumatology Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, SpainView further author information
,
Borja Hernández-BreijoImmuno-Rheumatology Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, SpainView further author information
,
Diana PeiteadoRheumatology Department, La Paz University Hospital, Madrid, SpainView further author information
,
Carolina TorneroRheumatology Department, La Paz University Hospital, Madrid, SpainView further author information
,
Dora Pascual-SalcedoImmuno-Rheumatology Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, SpainView further author information
&
Alejandro BalsaImmuno-Rheumatology Group, La Paz University Hospital Institute for Health Research (IdiPAZ), Madrid, Spain;Rheumatology Department, La Paz University Hospital, Madrid, SpainView further author information
 show all
Pages 538-540 | Received 28 Aug 2019, Accepted 16 Sep 2019, Published online: 27 Sep 2019

References

  • Van den Bemt BJF, den Broeder AA, Wolbink G, et al. The combined use of disease activity and infliximab serum trough concentrations for early prediction of (non-) response to infliximab in rheumatoid arthritis. Br J Clin Pharmacol. 2013;76(6):939–945.
  • Medina F, Plasencia C, Goupille P, et al. Current practice for therapeutic drug monitoring of iopharmaceuticals in rheumatoid arthritis. Ther Drug Monit. 2017;39(4):364–369.
  • Choi IY, Gerlag DM, Herenius MJ, et al. MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Ann Rheum Dis. 2015;74(3):499–505.
  • Inciarte-Mundo J, Ramirez J, Hernández MV, et al. Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity. Arthritis Res Ther. 2016;18(1):1–13.
  • Inciarte-Mundo J, Ruiz-Esquide V, Hernández MV, et al. Calprotectin more accurately discriminates the disease status of rheumatoid arthritis patients receiving tocilizumab than acute phase reactants. Rheumatology. 2015;53:1–5.
  • Hansson C, Eriksson C, Alenius G. S-Calprotectin (S100A8/S100A9): a potential marker of inflammation in patients with psoriatic arthritis. J Immunol Res. 2014;2014:1–5.
  • García-Arias M, Pascual-Salcedo D, Ramiro S, et al. Calprotectin in rheumatoid arthritis: association with disease activity in a cross-sectional and a longitudinal cohort. Mol Diagn Ther. 2013;17(1):49–56.
  • Hammer HB, Odegard S, Syversen SW, et al. Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69(1):150–154.
  • Pascual-Salcedo D, Plasencia C, Ramiro S, et al. Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis. Rheumatology. 2011;50(8):1445–1452.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.